Search





Search





Markets
/
Stocks
/
nasdaq-incr
/

InterCure Ltd

INCR

Add to Watchlist

0.820USD

0.0000.00%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

45.43MMarket Cap

LossP/E TTM



InterCure Ltd

0.820

0.0000.00%

Overview Financials Discussions Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of InterCure Ltd

Currency: USD Updated: 2026-05-15

Key Insights

InterCure Ltd's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered undervalued, ranking 60 out of 74 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

InterCure Ltd's Score

Industry at a Glance

Industry Ranking

60 / 74

Overall Ranking

469 / 4482

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

InterCure Ltd Highlights

StrengthsRisks

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Growing

The company is in a growing phase, with the latest annual income totaling USD 91.95M.

Fairly Valued

The company’s latest PE is -2.17, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 620.62K shares, decreasing 86.46% quarter-over-quarter.

Analyst Rating

Based on 0 analysts

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of InterCure Ltd is 3.54, ranking 74 out of 74 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

3.54

Change



Financials

6.34

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

0.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

1.37

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.98

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

5.00

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

InterCure Ltd's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of InterCure Ltd is 7.64, ranking 23 out of 74 in the Healthcare Providers & Services industry. Its current P/E ratio is -2.17, which is -10.98% below the recent high of -1.93 and -155.70% above the recent low of -5.55.

Score

Industry at a Glance

Previous score

7.64

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 60/74

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

No earnings forecast score is currently available for InterCure Ltd. The Healthcare Providers & Services industry's average is 7.57.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of InterCure Ltd is 6.76, ranking 52 out of 74 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 0.92 and the support level at 0.73, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.73

Change

0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.011

Neutral

RSI(14)

49.572

Neutral

STOCH(KDJ)(9,3,3)

12.559

Oversold

ATR(14)

0.054

Low Volatility

CCI(14)

-44.275

Neutral

Williams %R

61.538

Sell

TRIX(12,20)

0.261

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

0.818

Buy

MA10

0.833

Sell

MA20

0.838

Sell

MA50

0.796

Buy

MA100

0.866

Sell

MA200

1.177

Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Rabinovitch (Alexander)

14.24M

Healthcare Of Ontario Pension Plan

212.50K

Moore Capital Management, LP

Star Investors

97.27K

Renaissance Technologies LLC

Star Investors

71.60K

+12.40%

Citadel Advisors LLC

66.25K

+418.61%

Geode Capital Management, L.L.C.

22.54K

BlackRock Financial Management, Inc.

16.06K

-6.80%

Revisor Wealth Management LLC

11.88K

-6.06%

Quent Capital, LLC

10.32K

Quent Long Short Global Small Cap Fund LP

10.32K

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of InterCure Ltd is 2.33, ranking 62 out of 74 in the Healthcare Providers & Services industry. The company's beta value is 1.10. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.